In vitro experiments have demonstrated that silencing AKR1B10 effectively suppresses excessive proliferation and migration of HaCaT cells (Gao et al., 2017), further highlighting the potential therapeutic value of this target in psoriasis treatment. This evidence concerns the gene AKR1B10 and psoriasis.